Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Blattner

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2004
Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanismsRobert Winchester, Jane Pitt, Manhattan Charurat, et al.
The Journal of Infectious Diseases|January 29, 2003
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced womenRuth E Tuomala, Peter T O'Driscoll, James W Bremer, et al.
Cancer Epidemiology|May 25, 2012
Cancer incidence in Nigeria: a report from population-based cancer registriesElima Jedy-Agba, Maria Paula Curado, Olufemi Ogunbiyi, et al.
Vaccine|September 30, 2009
A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adultsXia Jin, Mark J Newman, Stephen De-Rosa, et al.
Plos One|May 21, 2010
Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factorsMan Charurat, Modupe Oyegunle, Renata Benjamin, et al.
AIDS Research and Therapy|November 4, 2020
Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in NigeriaNicaise Ndembi, Fati Murtala-Ibrahim, Monday Tola, et al.
Virology Journal|July 2, 2024
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AGLindsay Wieczorek, David Chang, Eric Sanders-Buell, et al.
Cancer Epidemiology|June 19, 2012
The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case StudyElima E Jedy-Agba, Maria-Paula Curado, Emmanuel Oga, et al.
Frontiers in Public Health|August 19, 2015
Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer RegistriesElima E Jedy-Agba, Emmanuel A Oga, Michael Odutola, et al.
Plos One|August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2004
Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanismsRobert Winchester, Jane Pitt, Manhattan Charurat, et al.
The Journal of Infectious Diseases|January 29, 2003
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced womenRuth E Tuomala, Peter T O'Driscoll, James W Bremer, et al.
Cancer Epidemiology|May 25, 2012
Cancer incidence in Nigeria: a report from population-based cancer registriesElima Jedy-Agba, Maria Paula Curado, Olufemi Ogunbiyi, et al.
Vaccine|September 30, 2009
A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adultsXia Jin, Mark J Newman, Stephen De-Rosa, et al.
Plos One|May 21, 2010
Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factorsMan Charurat, Modupe Oyegunle, Renata Benjamin, et al.
AIDS Research and Therapy|November 4, 2020
Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in NigeriaNicaise Ndembi, Fati Murtala-Ibrahim, Monday Tola, et al.
Virology Journal|July 2, 2024
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AGLindsay Wieczorek, David Chang, Eric Sanders-Buell, et al.
Cancer Epidemiology|June 19, 2012
The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case StudyElima E Jedy-Agba, Maria-Paula Curado, Emmanuel Oga, et al.
Frontiers in Public Health|August 19, 2015
Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer RegistriesElima E Jedy-Agba, Emmanuel A Oga, Michael Odutola, et al.
Plos One|August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
Pageof 4